Acyl glucuronides: biological activity, chemical reactivity, and chemical synthesis.

[1]  A. Siraki,et al.  Application of quantitative structure-toxicity relationships for acute NSAID cytotoxicity in rat hepatocytes. , 2005, Chemico-biological interactions.

[2]  F. Kauffman.  Conjugation—Deconjugation Reactions in Drug Metabolism and Toxicity , 1994, Handbook of Experimental Pharmacology.

[3]  C. King,et al.  Glucuronidation of carboxylic acid containing compounds by UDP-glucuronosyltransferase isoforms. , 2004, Archives of biochemistry and biophysics.

[4]  I. Wilson,et al.  Kinetic studies on the intramolecular acyl migration of β-1-O-acyl glucuronides: Application to the glucuronides of (R)- and (S)-ketoprofen, (R)- and (S)-hydroxy-ketoprofen metabolites, and tolmetin by 1H-NMR spectroscopy , 2005, Xenobiotica; the fate of foreign compounds in biological systems.

[5]  D. Keglević,et al.  Glucuronic Esters—III , 1965 .

[6]  W. Tang,et al.  Bioactivation of a toxic metabolite of valproic acid, (E)-2-propyl-2,4-pentadienoic acid, via glucuronidation. LC/MS/MS characterization of the GSH-glucuronide diconjugates. , 1996, Chemical research in toxicology.

[7]  G. R. Cannell,et al.  Inhibition of tubulin assembly and covalent binding to microtubular protein by valproic acid glucuronide in vitro. , 2002, Life sciences.

[8]  R. Kostiainen,et al.  Mass spectrometric and tandem mass spectrometric behavior of nitrocatechol glucuronides: A comparison of atmospheric pressure chemical ionization and electrospray ionization , 1999, Journal of the American Society for Mass Spectrometry.

[9]  B. Hamrén,et al.  Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[10]  P. Haycock,et al.  A comparison of quantitative NMR and radiolabelling studies of the metabolism and excretion of Statil (3-(4-bromo-2-fluorobenzyl)-4-oxo-3H-phthalazin-1-ylacetic acid) in the rat. , 2002, Journal of pharmaceutical and biomedical analysis.

[11]  S. Wrighton,et al.  Characterization by liquid chromatography-nuclear magnetic resonance spectroscopy and liquid chromatography-mass spectrometry of two coupled oxidative-conjugative metabolic pathways for 7-ethoxycoumarin in human liver microsomes treated with alamethicin. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[12]  I. Wilson,et al.  NMR and QSAR studies on the transacylation reactivity of model 1β-O-acyl glucuronides. I: design, synthesis and degradation rate measurement , 2004, Xenobiotica; the fate of foreign compounds in biological systems.

[13]  I. Wilson,et al.  The application of high performance liquid chromatography, coupled to nuclear magnetic resonance spectroscopy and mass spectrometry (HPLC-NMR-MS), to the characterisation of ibuprofen metabolites from human urine , 1998 .

[14]  R. Dickinson,et al.  Studies on the reactivity of acyl glucuronides--I. Phenolic glucuronidation of isomers of diflunisal acyl glucuronide in the rat. , 1991, Biochemical pharmacology.

[15]  C. Fenselau,et al.  Reaction of 1-O-acyl glucuronides with 4-(p-nitrobenzyl)pyridine. , 1986, Drug metabolism and disposition: the biological fate of chemicals.

[16]  T. Ebner,et al.  Disposition and chemical stability of telmisartan 1-O-acylglucuronide. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[17]  Kumiko Mushiake,et al.  Chemical synthesis of 24-beta-D-galactopyranosides of bile acids: a new type of bile acid conjugates in human urine. , 2005, Chemistry and physics of lipids.

[18]  R. Barnaby,et al.  Human hepatic metabolism of a novel 2-carboxyindole glycine antagonist for stroke: in vitro-in vivo correlations , 2000, Xenobiotica; the fate of foreign compounds in biological systems.

[19]  David M. Shackleford,et al.  Stereoselective Hepatic Disposition of Model Diastereomeric Acyl Glucuronides , 2004, Journal of Pharmacokinetics and Pharmacodynamics.

[20]  B. Ma,et al.  GLYCOSIDATION OF AN ENDOTHELIN ETA RECEPTOR ANTAGONIST AND DICLOFENAC IN HUMAN LIVER MICROSOMES: AGLYCONE-DEPENDENT UDP-SUGAR SELECTIVITY , 2005, Drug Metabolism and Disposition.

[21]  R. Aster,et al.  Immune thrombocytopenia resulting from sensitivity to metabolites of naproxen and acetaminophen. , 2001, Blood.

[22]  In vitro and in vivo studies on acyl-coenzyme A-dependent bioactivation of zomepirac in rats. , 2005, Chemical research in toxicology.

[23]  D. Holt,et al.  Effective synthesis of 1beta-acyl glucuronides by selective acylation. , 2005, Organic letters.

[24]  B. K. Park,et al.  Syntheses and characterization of the acyl glucuronide and hydroxy metabolites of diclofenac. , 2004, Journal of medicinal chemistry.

[25]  H. Nau,et al.  Synthesis, high-performance liquid chromatography-nuclear magnetic resonance characterization and pharmacokinetics in mice of CD271 glucuronide. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[26]  K. Bock.  Vertebrate UDP-glucuronosyltransferases: functional and evolutionary aspects. , 2003, Biochemical pharmacology.

[27]  N. Mano,et al.  Rapid and simple quantitative assay method for diastereomeric flurbiprofen glucuronides in the incubation mixture. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[28]  R. Kostiainen,et al.  Electrospray and atmospheric pressure chemical ionization tandem mass spectrometric behavior of eight anabolic steroid glucuronides , 2000, Journal of the American Society for Mass Spectrometry.

[29]  K. Kakehi,et al.  In vitro regioselective stability of beta-1-O- and 2-O-acyl glucuronides of naproxen and their covalent binding to human serum albumin. , 1999, Journal of pharmaceutical sciences.

[30]  M. Nakajima,et al.  Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[31]  C. Rice-Evans,et al.  Modulation of Pro-survival Akt/Protein Kinase B and ERK1/2 Signaling Cascades by Quercetin and Its in Vivo Metabolites Underlie Their Action on Neuronal Viability* , 2003, Journal of Biological Chemistry.

[32]  D. Lightner,et al.  Synthesis and metabolism of the first thia-bilirubin. , 2001, The Journal of organic chemistry.

[33]  Y. Shinohara,et al.  Studies on the stereoselective internal acyl migration of ketoprofen glucuronides using 13C labeling and nuclear magnetic resonance spectroscopy. , 1998, Drug metabolism and disposition: the biological fate of chemicals.

[34]  T. Hashimoto,et al.  Rapid internal acyl migration and protein binding of synthetic probenecid glucuronides. , 2002, Chemical Research in Toxicology.

[35]  W. Krol,et al.  Pharmacokinetics of dibutylphthalate in pregnant rats. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[36]  S. Hansen,et al.  Stereospecific pH-dependent degradation kinetics of R- and S-naproxen-beta-l-O-acyl-glucuronide. , 2002, Chirality.

[37]  D. Marguet,et al.  Hepatic covalent adduct formation with zomepirac in the CD26‐deficient mouse , 2002, Journal of gastroenterology and hepatology.

[38]  H. Leis,et al.  Quantitative gas chromatographic/mass spectrometric analysis of morphine glucuronides in human plasma by negative ion chemical ionization mass spectrometry. , 2002, Journal of mass spectrometry : JMS.

[39]  J. Weekley,et al.  Bioactivation of carboxylic acid compounds by UDP-Glucuronosyltransferases to DNA-damaging intermediates: role of glycoxidation and oxidative stress in genotoxicity. , 2006, Chemical research in toxicology.

[40]  J. Magdalou,et al.  Glycation of human serum albumin by acylglucuronides of nonsteroidal anti-inflammatory drugs of the series of phenylpropionates. , 1999, Life Science.

[41]  Hiromi Ito,et al.  Enantioselective immunorecognition of protein modification with optically active ibuprofen using polyclonal antibody. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[42]  B. Baguley,et al.  Identification and reactivity of the major metabolite (ß-1-glucuronide) of the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in humans , 2001, Xenobiotica; the fate of foreign compounds in biological systems.

[43]  V. Armstrong,et al.  Acyl Glucuronide Drug Metabolites: Toxicological and Analytical Implications , 2003, Therapeutic drug monitoring.

[44]  I. Wilson,et al.  Development of a simple liquid chromatographic method for the separation of mixtures of positional isomers and anomers of synthetic 2-, 3- and 4-fluorobenzoic acid glucuronides formed via acyl migration reactions. , 1996, Journal of chromatography. B, Biomedical applications.

[45]  J. Ware,et al.  Immunochemical detection and identification of protein adducts of diclofenac in the small intestine of rats: possible role in allergic reactions. , 1998, Chemical research in toxicology.

[46]  Liang-Shang Gan,et al.  Disposition of 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2'- (methylsulfonyl)-[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)- 1H-pyrazole-5-carboxamide (DPC 423) by novel metabolic pathways. Characterization of unusual metabolites by liquid chromatography/mass spectrometry and NMR. , 2002, Chemical research in toxicology.

[47]  R. Schmidt,et al.  Stereoselective glycosidations of uronic acids , 1980 .

[48]  C. Fenselau,et al.  Characterization and formation of the glutathione conjugate of clofibric acid. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[49]  A. D. Rodrigues,et al.  GLUCURONIDATION CONVERTS GEMFIBROZIL TO A POTENT, METABOLISM-DEPENDENT INHIBITOR OF CYP2C8: IMPLICATIONS FOR DRUG-DRUG INTERACTIONS , 2006, Drug Metabolism and Disposition.

[50]  M. Lhermitte,et al.  Identification and quantitation of xenobiotics by 1H NMR spectroscopy in poisoning cases. , 2003, Forensic science international.

[51]  D. Lightner,et al.  Synthesis, Conformation, and Metabolism of a Selenium Bilirubin , 2004 .

[52]  K. Tomer,et al.  Effect of nonenzymatic glycation of albumin and superoxide dismutase by glucuronic acid and suprofen acyl glucuronide on their functions in vitro. , 1999, Chemico-biological interactions.

[53]  K. Cassidy,et al.  Preclinical characterization of 2-[3-[3-[(5-ethyl-4'-fluoro-2-hydroxy[1,1'-biphenyl]-4-yl)oxy]propoxy]-2-propylphenoxy]benzoic acid metabolism: in vitro species comparison and in vivo disposition in rats. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[54]  A. Barua,et al.  All-trans-retinoyl beta-glucuronide: new procedure for chemical synthesis and its metabolism in vitamin A-deficient rats. , 1996, The Biochemical journal.

[55]  A L Burlingame,et al.  Mechanisms for covalent binding of benoxaprofen glucuronide to human serum albumin. Studies By tandem mass spectrometry. , 1998, Drug metabolism and disposition: the biological fate of chemicals.

[56]  R. R. Schmidt,et al.  Einfache Synthese von ß-D-Glucopyranosyluronaten , 1981 .

[57]  J. Goto,et al.  Synthesis of Bile Acid 24-acyl Glucuronides , 1998, Steroids.

[58]  I. Wilson,et al.  NMR spectroscopic studies of the transacylation reactivity of ibuprofen 1-beta-O-acyl glucuronide. , 2006, Journal of pharmaceutical and biomedical analysis.

[59]  Yuan-qing Xia,et al.  SPECIES DIFFERENCES IN THE ELIMINATION OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONIST HIGHLIGHTED BY OXIDATIVE METABOLISM OF ITS ACYL GLUCURONIDE , 2005, Drug Metabolism and Disposition.

[60]  Shufeng Zhou,et al.  Preclinical factors influencing the relative contributions of Phase I and II enzymes to the metabolism of the experimental anti-cancer drug 5,6-dimethylxanthenone-4-acetic acid. , 2003, Biochemical pharmacology.

[61]  I. Wilson,et al.  Assignment of the 750 MHz 1H NMR resonances from a mixture of transacylated ester glucuronic acid conjugates with the aid of oversampling and digital filtering during acquisition. , 1995, Journal of pharmaceutical and biomedical analysis.

[62]  A. Stachulski,et al.  The synthesis of O-glucuronides. , 1998, Natural product reports.

[63]  David M. Shackleford,et al.  A small-scale synthesis and enantiomeric resolution of (RS)-[1-14C]-2-Phenylpropionic acid and biosynthesis of its diastereomeric acyl glucuronides , 2001 .

[64]  I. Yamatsu,et al.  Synthesis of glucuronides of α,β-unsaturated carboxylic acids , 1993 .

[65]  I. Wilson,et al.  Identification of the Positional Isomers of 2-Fluorobenzoic acid 1-O-Acyl Glucuronide by Directly Coupled HPLC-NMR , 1995 .

[66]  R. Dickinson,et al.  Studies on the reactivity of acyl glucuronides--II. Interaction of diflunisal acyl glucuronide and its isomers with human serum albumin in vitro. , 1991, Biochemical pharmacology.

[67]  Ernesto Callegari,et al.  A comprehensive listing of bioactivation pathways of organic functional groups. , 2005, Current drug metabolism.

[68]  M. Bailey,et al.  Acyl glucuronide reactivity in perspective: biological consequences. , 2003, Chemico-biological interactions.

[69]  T. Yoshioka,et al.  Synthesis of 1-beta-O-acyl glucuronides of diclofenac, mefenamic acid and (S)-naproxen by the chemo-selective enzymatic removal of protecting groups from the corresponding methyl acetyl derivatives. , 2006, Organic & biomolecular chemistry.

[70]  B. Ransil,et al.  Hepatic microsomal bilirubin UDP-glucuronosyltransferase. The kinetics of bilirubin mono- and diglucuronide synthesis. , 1992, Journal of Biological Chemistry.

[71]  T. Baillie,et al.  Extrapolation of Diclofenac Clearance from in Vitro Microsomal Metabolism Data: Role of Acyl Glucuronidation and Sequential Oxidative Metabolism of the Acyl Glucuronide , 2002, Journal of Pharmacology and Experimental Therapeutics.

[72]  L. Benet,et al.  Acyl glucuronides revisited: is the glucuronidation process a toxification as well as a detoxification mechanism? , 1992, Drug metabolism reviews.

[73]  W. Humphreys,et al.  BIOTRANSFORMATION OF CARBON-14-LABELED MURAGLITAZAR IN MALE MICE: INTERSPECIES DIFFERENCE IN METABOLIC PATHWAYS LEADING TO UNIQUE METABOLITES , 2006, Drug Metabolism and Disposition.

[74]  A. Vickers,et al.  In vitro metabolism of tegaserod in human liver and intestine: assessment of drug interactions. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[75]  Y. Kato,et al.  Species differences in absorption, metabolism and excretion of pranoprofen, a 2-arylpropionic acid derivative, in experimental animals. , 1990, Journal of pharmacobio-dynamics.

[76]  A. Robichaud,et al.  The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[77]  R. O. Oude Elferink,et al.  Selective protein adduct formation of diclofenac glucuronide is critically dependent on the rat canalicular conjugate export pump (Mrp2). , 1998, Chemical research in toxicology.

[78]  E M Faed,et al.  Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs. , 1984, Drug metabolism reviews.

[79]  B. Sallustio,et al.  Reactivity of gemfibrozil 1-o-beta-acyl glucuronide. Pharmacokinetics of covalently bound gemfibrozil-protein adducts in rats. , 1995, Drug Metabolism And Disposition.

[80]  J. Goto,et al.  Separatory determination of diastereomeric ibuprofen glucuronides in human urine by liquid chromatography/electrospray ionization-mass spectrometry. , 1998, Biomedical chromatography : BMC.

[81]  S. Harigaya,et al.  Metabolism of ethyl 2-(4-chlorophenyl)-5-(2-furyl)-oxazole-4-acetate, a new hypolipidemic agent, in the rat, rabbit, and dog. Glucuronidation of carboxyl group and cleavage of furan ring. , 1987, Drug Metabolism And Disposition.

[82]  V. Armstrong,et al.  Induction of cytokine release by the acyl glucuronide of mycophenolic acid: a link to side effects? , 2000, Clinical biochemistry.

[83]  P. Hoffmann,et al.  A new protected form of glucuronic acid for the synthesis of labile 1-O-acyl-β-D-glucuronides , 1989 .

[84]  N. Mano,et al.  Inhibition of the rat hepatic microsomal flurbiprofen acyl glucuronidation by bile acids. , 2003, Journal of pharmaceutical sciences.

[85]  E. Francotte,et al.  Preparative Enzymatic Synthesis of the Acylglucuronide of Mycophenolic Acid , 2003 .

[86]  GLUCURONIDATION AS A MAJOR METABOLIC CLEARANCE PATHWAY OF 14C-LABELED MURAGLITAZAR IN HUMANS: METABOLIC PROFILES IN SUBJECTS WITH OR WITHOUT BILE COLLECTION , 2006, Drug Metabolism and Disposition.

[87]  S. Hansen,et al.  S-naproxen-beta-1-O-acyl glucuronide degradation kinetic studies by stopped-flow high-performance liquid chromatography-1H NMR and high-performance liquid chromatography-UV. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[88]  R. Schmidt.  New Methods for the Synthesis of Glycosides and Oligosaccharides ‐ Are there Alternatives to the Koenigs‐Knorr‐Method? , 1986 .

[89]  L. Benet,et al.  Enantioselective covalent binding of 2-phenylpropionic Acid to protein in vitro in rat hepatocytes. , 2002, Chemical research in toxicology.

[90]  N. Mano,et al.  Potential bile acid metabolites. 24. An efficient synthesis of carboxyl-linked glucosides and their chemical properties , 2002, Lipids.

[91]  Martin Hofmann,et al.  Directly Coupled 800 MHz HPLC−NMR Spectroscopy of Urine and Its Application to the Identification of the Major Phase II Metabolites of Tolfenamic Acid , 1997 .

[92]  C. Huselton,et al.  Synthesis of Novel Glucuronide Conjugates of Retinoid Carboxylic Acids , 1996 .

[93]  M. Bailey,et al.  Zomepirac acyl glucuronide covalently modifies tubulin in vitro and in vivo and inhibits its assembly in an in vitro system. , 1998, Chemico-biological interactions.

[94]  M. Jemal,et al.  METABOLISM OF [14C]GEMOPATRILAT AFTER ORAL ADMINISTRATION TO RATS, DOGS, AND HUMANS , 2006, Drug Metabolism and Disposition.

[95]  B. K. Park,et al.  FORMATION AND PROTEIN BINDING OF THE ACYL GLUCURONIDE OF A LEUKOTRIENE B4 ANTAGONIST (SB-209247): RELATION TO SPECIES DIFFERENCES IN HEPATOTOXICITY , 2005, Drug Metabolism and Disposition.

[96]  G. Valaskovic,et al.  Ultra-low flow nanospray for the normalization of conventional liquid chromatography/mass spectrometry through equimolar response: standard-free quantitative estimation of metabolite levels in drug discovery. , 2006, Rapid communications in mass spectrometry : RCM.

[97]  S. Harper,et al.  Preclinical pharmacokinetics and metabolism of a potent non-nucleoside inhibitor of the hepatitis C virus NS5B polymerase , 2005, Xenobiotica; the fate of foreign compounds in biological systems.

[98]  I. Wilson,et al.  NMR spectroscopic and theoretical chemistry studies on the internal acyl migration reactions of the 1-O-acyl-beta-D-glucopyranuronate conjugates of 2-, 3-, and 4-(trifluoromethyl) benzoic acids. , 1996, Chemical research in toxicology.

[99]  R. Barnaby,et al.  Pharmacokinetics, metabolism and excretion of the glycine antagonist GV150526A in rat and dog , 2003, Xenobiotica; the fate of foreign compounds in biological systems.

[100]  F. Kaspersen,et al.  A review of the methods of chemical synthesis of sulphate and glucuronide conjugates. , 1987, Xenobiotica; the fate of foreign compounds in biological systems.

[101]  T Hashimoto,et al.  Kinetics of intramolecular acyl migration of 1beta-O-acyl glucuronides of (R)- and (S)-2-phenylpropionic acids. , 2001, Biological & pharmaceutical bulletin.

[102]  F. Fontaine,et al.  UDP-glucuronosyltransferase-dependent bioactivation of clofibric acid to a DNA-damaging intermediate in mouse hepatocytes. , 2003, Chemico-biological interactions.

[103]  I. Wilson,et al.  pH dependent formation of beta-glucuronidase resistant conjugates from the biosynthetic ester glucuronide of isoxepac. , 1981, Biochemical pharmacology.

[104]  J C Lindon,et al.  Nuclear magnetic resonance (NMR) and quantitative structure–activity relationship (QSAR) studies on the transacylation reactivity of model 1β-O-acyl glucuronides. II: QSAR modelling of the reaction using both computational and experimental NMR parameters , 2004, Xenobiotica; the fate of foreign compounds in biological systems.

[105]  B. Ma,et al.  Acyl glucuronidation and glucosidation of a new and selective endothelin ET(A) receptor antagonist in human liver microsomes. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[106]  G. Blaschke,et al.  Capillary electrophoresis-mass spectrometry, liquid chromatography-mass spectrometry and nanoelectrospray-mass spectrometry of praziquantel metabolites. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[107]  V. Armstrong,et al.  Identification of glucoside and carboxyl‐linked glucuronide conjugates of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil , 1999, British journal of pharmacology.

[108]  J. Magdalou,et al.  Stereoselective irreversible binding of ketoprofen glucuronides to albumin. Characterization of the site and the mechanism. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[109]  I. Wilson,et al.  750 MHz HPLC-NMR spectroscopic studies on the separation and characterization of the positional isomers of the glucuronides of 6,11-dihydro-11-oxodibenz[b,e]oxepin-2-acetic acid. , 1996, Analytical chemistry.

[110]  S. Hansen,et al.  LC-1H NMR used for determination of the elution order of S-naproxen glucuronide isomers in two isocratic reversed-phase LC-systems. , 2001, Journal of pharmaceutical and biomedical analysis.

[111]  D. Dalvie,et al.  Metabolism of CP-195,543, a leukotriene B4 receptor antagonist, in the Long-Evans rat and Cynomolgus monkey. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[112]  K. Shimada,et al.  Analysis of acetaminophen glucuronide conjugate accompanied by adduct ion production by liquid chromatography-atmospheric pressure chemical ionization-mass spectrometry. , 2003, Journal of pharmaceutical and biomedical analysis.

[113]  N. Mano,et al.  Synthesis and characterization of deoxycholyl 2-deoxyglucuronide: A water-soluble affinity labeling reagent , 2003, Lipids.

[114]  I. Wilson,et al.  Measurement of Internal Acyl Migration Reaction Kinetics Using Directly Coupled HPLC-NMR:  Application for the Positional Isomers of Synthetic (2-Fluorobenzoyl)-d-glucopyranuronic Acid. , 1996, Analytical chemistry.

[115]  L. Benet,et al.  Studies on the chemical reactivity of 2-phenylpropionic acid 1-O-acyl glucuronide and S-acyl-CoA thioester metabolites. , 2002, Chemical research in toxicology.

[116]  U. Boelsterli.  REACTIVE ACYL GLUCURONIDES: POSSIBLE ROLE IN SMALL INTESTINAL TOXICITY INDUCED BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS , 1999 .

[117]  C. Bedford,et al.  Glucuronic acid conjugates. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[118]  J. Yuan,et al.  Characterization of metabolites of Celecoxib in rabbits by liquid chromatography/tandem mass spectrometry. , 2000, Journal of mass spectrometry : JMS.

[119]  U. Boelsterli.  Xenobiotic acyl glucuronides and acyl CoA thioesters as protein-reactive metabolites with the potential to cause idiosyncratic drug reactions. , 2002, Current drug metabolism.

[120]  Shufeng Zhou,et al.  Determination of two major metabolites of the novel anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid in hepatic microsomal incubations by high-performance liquid chromatography with fluorescence detection , 1999 .

[121]  M. Davis,et al.  Metabolic activation of diclofenac by human cytochrome P450 3A4: role of 5-hydroxydiclofenac. , 1999, Chemical research in toxicology.

[122]  R. Nation,et al.  Hepatic disposition of the acyl glucuronide1-O-gemfibrozil-beta-D-glucuronide: effects of dibromosulfophthalein on membrane transport and aglycone formation. , 1999, The Journal of pharmacology and experimental therapeutics.

[123]  V. Armstrong,et al.  Identification of protein targets for mycophenolic acid acyl glucuronide in rat liver and colon tissue , 2004, Proteomics.

[124]  T. Ohkawa,et al.  Rapid LC-TOFMS method for identification of binding sites of covalent acylglucuronide-albumin complexes. , 2003, Journal of pharmaceutical and biomedical analysis.

[125]  F. Azam,et al.  A novel approach for predicting acyl glucuronide reactivity via Schiff base formation: development of rapidly formed peptide adducts for LC/MS/MS measurements. , 2004, Chemical research in toxicology.

[126]  T. Hsia,et al.  INHIBITION OF LUNG CANCER CELL GROWTH BY QUERCETIN GLUCURONIDES VIA G2/M ARREST AND INDUCTION OF APOPTOSIS , 2006, Drug Metabolism and Disposition.

[127]  P. Inskeep,et al.  Tissue distribution and biotransformation of zopolrestat, an aldose reductase inhibitor, in rats. , 1998, Drug metabolism and disposition: the biological fate of chemicals.

[128]  H. Kunz,et al.  Solid Phase Synthesis of Peptides and Glycopeptides on Polymeric Supports with Allylic Anchor Groups , 1988 .

[129]  M. Ohashi,et al.  Hopantenic acid beta-glucoside as a new urinary metabolite of calcium hopantenate in dogs. , 1986, Drug Metabolism And Disposition.

[130]  A. Akin,et al.  Preparation of CI‐1027 Glucuronide: Metabolite of a Remarkable Lipid‐Modulating Agent , 2005 .

[131]  W. Thormann,et al.  Analysis of codeine, dihydrocodeine and their glucuronides in human urine by electrokinetic capillary immunoassays and capillary electrophoresis-ion trap mass spectrometry. , 2000, Journal of chromatography. A.

[132]  C. Larsen,et al.  Metabolism and excretion of citalopram in man: identification of O-acyl- and N-glucuronides. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[133]  Y. Shinohara,et al.  Stereoselective internal acyl migration of 1beta-O-acyl glucuronides of enantiomeric 2-phenylpropionic acids. , 2000, Biological & pharmaceutical bulletin.